Cathepsin B, Human, Recombinant, Carrier-free

データシート

• 商品コード：953-CY-010
• メーカー：RSD
• 包装：10μg
• 価格： ¥90,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Simmons G et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. U.S.A. 2005 Aug;102(33):11876-81
  Simmons G et al
  2005/01/01
  
• 備考：
  Application: Enzyme Activity, Sample Type: SARS-CoV
• 参照：
  

• No.： 2
• 文献情報：
  Gocheva V et al. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 2006 Mar;20(5):543-56
  Gocheva V et al
  2006/01/01
  
• 備考：
  Application: Enzyme Assay, Sample Type: Buffer
• 参照：
  

• No.： 3
• 文献情報：
  Cheng T et al. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification. J. Biol. Chem. 2006 Jun;281(2
  Cheng T et al
  2006/01/01
  
• 備考：
  Application: Enzyme Activity, Sample Type: TGase 3 zymogen
• 参照：
  

• No.： 4
• 文献情報：
  Burster T et al. Design of protease-resistant myelin basic protein-derived peptides by cleavage site directed amino acid substitutions. Biochem. Pharmacol. 2007 Nov;74(10):1514-23
  Burster T et al
  2007/01/01
  
• 備考：
  Species: Human, Application: Enzyme Activity, Sample type: Cell Lysates
• 参照：
  

• No.： 5
• 文献情報：
  Patel N et al. A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase. J. Clin. Invest. 2009 Jul;119(7):1964-73
  Patel N et al
  2009/01/01
  
• 備考：
  Application: Enzyme Activity, Sample Type: Cell Lysates
• 参照：
  

• No.： 6
• 文献情報：
  Dimasi N et al. The design and characterization of oligospecific antibodies for simultaneous targeting of multiple disease mediators. J. Mol. Biol. 2009 Oct;393(3):672-92
  Dimasi N et al
  2009/01/01
  
• 備考：
  Application: Enzyme Assay, Sample Type: Fluorogenic Substrate,Serum
• 参照：
  

• No.： 7
• 文献情報：
  Guery L et al. Fine-tuning nucleophosmin in macrophage differentiation and activation. Blood 2011 Oct;118(17):4694-704
  Guery L et al
  2011/01/01
  
• 備考：
  Application: Cleavage, Sample Type: recombinant nucleophosmin
• 参照：
  

• No.： 8
• 文献情報：
  Bruchard M et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat. Med. 2013 Jan;19(1):57-64
  Bruchard M et al
  2013/01/01
  
• 備考：
  Application: Surface Plasmon Resonance, Sample Type: N/A
• 参照：
  

• No.： 9
• 文献情報：
  Jiang H et al. Cathepsin K-mediated Notch1 activation contributes to neovascularization in response to hypoxia. Nat Commun 2014;5:3838
  Jiang H et al
  2014/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Muscle Extracts
• 参照：
  

• No.： 10
• 文献情報：
  Shivanna V et al. Endosomal acidification and cathepsin L activity is required for calicivirus replication. Virology 2014 Sep;464-465:287-95
  Shivanna V et al
  2014/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：